Bone marrow microenvironment: A newly recognized target for diabetes-induced cellular damage

Giuseppe Mangialardi, Atsuhiko Oikawa, Carlotta Reni, Paolo Madeddu

Research output: Contribution to journalArticle

Abstract

Diabetes mellitus is considered a cardiovascular disease owing to its prevalent association with cardiovascular morbidity and mortality. Cardiovascular events are not only more frequent but also complicated with more severe outcomes in diabetic patients as compared with non-diabetic patients. One mechanism accounting for this difference consists of the impairment of the regenerative cellular machinery, which contributes to tissue healing. Recent evidence indicates the contribution of resident progenitor cells in post-ischemic tissue remodeling. In addition, a wide spectrum of cells from distant sources, including the bone marrow, is attracted and home to the healing tissue. Diabetes affects the process of mobilization and recruitment as well as intrinsic functional properties of bone marrow-derived progenitor cells. This review highlights current evidence for diabetes-induced damage of bone marrow hematopoietic progenitor cells in the endosteal and vascular niches.

Original languageEnglish
Pages (from-to)159-167
Number of pages9
JournalEndocrine, Metabolic and Immune Disorders - Drug Targets
Volume12
Issue number2
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Bone Marrow
Stem Cells
Hematopoietic Stem Cells
Blood Vessels
Diabetes Mellitus
Cardiovascular Diseases
Morbidity
Mortality

Keywords

  • Bone marrow
  • Diabetes
  • Ischemia
  • Microenvironment
  • Osteoblastic niche
  • Stem cells
  • Vascular niche

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy

Cite this

Bone marrow microenvironment : A newly recognized target for diabetes-induced cellular damage. / Mangialardi, Giuseppe; Oikawa, Atsuhiko; Reni, Carlotta; Madeddu, Paolo.

In: Endocrine, Metabolic and Immune Disorders - Drug Targets, Vol. 12, No. 2, 06.2012, p. 159-167.

Research output: Contribution to journalArticle

@article{3abf56ffbf824784b923c3726e63a994,
title = "Bone marrow microenvironment: A newly recognized target for diabetes-induced cellular damage",
abstract = "Diabetes mellitus is considered a cardiovascular disease owing to its prevalent association with cardiovascular morbidity and mortality. Cardiovascular events are not only more frequent but also complicated with more severe outcomes in diabetic patients as compared with non-diabetic patients. One mechanism accounting for this difference consists of the impairment of the regenerative cellular machinery, which contributes to tissue healing. Recent evidence indicates the contribution of resident progenitor cells in post-ischemic tissue remodeling. In addition, a wide spectrum of cells from distant sources, including the bone marrow, is attracted and home to the healing tissue. Diabetes affects the process of mobilization and recruitment as well as intrinsic functional properties of bone marrow-derived progenitor cells. This review highlights current evidence for diabetes-induced damage of bone marrow hematopoietic progenitor cells in the endosteal and vascular niches.",
keywords = "Bone marrow, Diabetes, Ischemia, Microenvironment, Osteoblastic niche, Stem cells, Vascular niche",
author = "Giuseppe Mangialardi and Atsuhiko Oikawa and Carlotta Reni and Paolo Madeddu",
year = "2012",
month = "6",
doi = "10.2174/187153012800493530",
language = "English",
volume = "12",
pages = "159--167",
journal = "Endocrine, Metabolic and Immune Disorders - Drug Targets",
issn = "1871-5303",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Bone marrow microenvironment

T2 - A newly recognized target for diabetes-induced cellular damage

AU - Mangialardi, Giuseppe

AU - Oikawa, Atsuhiko

AU - Reni, Carlotta

AU - Madeddu, Paolo

PY - 2012/6

Y1 - 2012/6

N2 - Diabetes mellitus is considered a cardiovascular disease owing to its prevalent association with cardiovascular morbidity and mortality. Cardiovascular events are not only more frequent but also complicated with more severe outcomes in diabetic patients as compared with non-diabetic patients. One mechanism accounting for this difference consists of the impairment of the regenerative cellular machinery, which contributes to tissue healing. Recent evidence indicates the contribution of resident progenitor cells in post-ischemic tissue remodeling. In addition, a wide spectrum of cells from distant sources, including the bone marrow, is attracted and home to the healing tissue. Diabetes affects the process of mobilization and recruitment as well as intrinsic functional properties of bone marrow-derived progenitor cells. This review highlights current evidence for diabetes-induced damage of bone marrow hematopoietic progenitor cells in the endosteal and vascular niches.

AB - Diabetes mellitus is considered a cardiovascular disease owing to its prevalent association with cardiovascular morbidity and mortality. Cardiovascular events are not only more frequent but also complicated with more severe outcomes in diabetic patients as compared with non-diabetic patients. One mechanism accounting for this difference consists of the impairment of the regenerative cellular machinery, which contributes to tissue healing. Recent evidence indicates the contribution of resident progenitor cells in post-ischemic tissue remodeling. In addition, a wide spectrum of cells from distant sources, including the bone marrow, is attracted and home to the healing tissue. Diabetes affects the process of mobilization and recruitment as well as intrinsic functional properties of bone marrow-derived progenitor cells. This review highlights current evidence for diabetes-induced damage of bone marrow hematopoietic progenitor cells in the endosteal and vascular niches.

KW - Bone marrow

KW - Diabetes

KW - Ischemia

KW - Microenvironment

KW - Osteoblastic niche

KW - Stem cells

KW - Vascular niche

UR - http://www.scopus.com/inward/record.url?scp=84861166750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861166750&partnerID=8YFLogxK

U2 - 10.2174/187153012800493530

DO - 10.2174/187153012800493530

M3 - Article

C2 - 22236024

AN - SCOPUS:84861166750

VL - 12

SP - 159

EP - 167

JO - Endocrine, Metabolic and Immune Disorders - Drug Targets

JF - Endocrine, Metabolic and Immune Disorders - Drug Targets

SN - 1871-5303

IS - 2

ER -